Finch Therapeutics Group, Inc.
FNCHDelisted Oct 31, 2024- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001733257
Finch Therapeutics Group, Inc. was delisted on Oct 31, 2024; its insiders filed their last Form 4 on Jun 10, 2024; no institution reported holding it in 13F filings for Q3 2024; no superinvestor held it.
Q4 2021 vs. Q3 2021
How the institutions holding Finch Therapeutics Group, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 45 | 51 | +6 |
| Shares | 8.21M | 11.5M | +3.32M (+40.4%) |
| Value | $106.8M | $115.0M | +$8.18M (+7.7%) |
New holders (9)
Institutions that held Finch Therapeutics Group, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Avenir Management Company, LLC | 1,663,366 | $16.6M | 8.89% |
| Citadel Advisors LLC | 77,324 | $771.0K | 0.00% |
| Ergoteles LLC | 63,881 | $637.0K | 0.02% |
| SCS Capital Management LLC | 38,294 | $382.0K | 0.01% |
| Renaissance Technologies LLC | 37,686 | $376.0K | 0.00% |
| D. E. Shaw & Co., Inc. | 27,444 | $274.0K | 0.00% |
| Qube Research & Technologies Ltd | 24,503 | $244.0K | 0.00% |
| Millennium Management LLC | 12,642 | $126.0K | 0.00% |
| Lazard Asset Management LLC | 150 | $1.00K | 0.00% |
Sold out (3)
Institutions that held Finch Therapeutics Group, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| First Midwest Bank Trust Division | 26,344 | $342.0K |
| Vontobel Holding Ltd. | 25,000 | $325.0K |
| Piscataqua Savings Bank | 400 | $5.00K |